Dr. Abdul Ahad Khan, MD

Dr. Khan practices at Memorial Medical Center in Las Cruces, New Mexico, part of Lifepoint Health.

Dr. Khan's NPI, 1528449576, was assigned on June 16, 2015. Dr. Khan graduated from Aga Khan Medical College in 2014. Dr. Khan holds New Mexico license MD2022-0011.

Dr. Khan's primary practice is Memorial Medical Center, at 2450 South Telshor Blvd, Las Cruces, NM 88011 in Dona Ana County. The practice phone is (575) 522-8641.

Dr. Khan's primary practice is Memorial Medical Center in Las Cruces, New Mexico, part of Lifepoint Health. Dr. Khan is also affiliated with MountainView Regional Medical Center. The medical group on file is New Mexico Cardiovascular Associates. Dmand AI also links Dr. Khan to 3 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Khan practices, 6 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Khan's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Khan is licensed in New Mexico.

Dmand AI lists aneurysm, angioplasty, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, chronic hypertension, coronary artery disease and heart bypass surgery among the conditions Dr. Khan treats.

CMS data shows 1,913 Medicare services from Dr. Khan across 24 procedure codes in 2024, for 840 Medicare patients. Medicare paid $117,651 for them.

CMS counts 840 Medicare patients who saw Dr. Khan in 2024. The largest group is 75 to 84, with 305 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 1.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Khan's median patient age at 71, with 54% women.

In 2024, Dr. Khan wrote 3,616 Medicare Part D claims for 487 patients. 85% of them were for generic drugs. CMS names the drug for 3,429 of them, across 32 drugs with 11 or more claims each, at $639,806 in total drug cost. In 2023, CMS named 1,623 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Khan for performance year 2024, reported as part of a group. Dr. Khan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Khan as offering telehealth. CMS counts 32 procedures of coronary angioplasty and stenting by Dr. Khan, more than 68% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 11 papers to Dr. Khan, published from 2018 to 2022. 2020 was the busiest year, with 3. The most frequent topics are Percutaneous Coronary Intervention, Coronary Artery Disease and Atherectomy, Coronary. Dr. Khan has published most often in Cardiovasc Revasc Med. Dr. Khan's most frequent co-authors are Debabrata P. Mukherjee, MD, Timir Kumar Paul, MD and Subhash Banerjee, MD.

CMS Open Payments shows 219 general payments to Dr. Khan from 28 drug and device companies from 2022 to 2025. Travel and lodging make up the largest share, 57% of the total. Abbott Laboratories paid the most, $6,930.

Dr. Khan graduated from Aga Khan Medical College in 2014.

Dr. Khan is in network with 11 carriers, including Aetna, Elevance and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.